Terms: = Breast cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Treatment
22 results:
1. Comprehending the cuproptosis and cancer-immunity cycle network: delving into the immune landscape and its predictive role in breast cancer immunotherapy responses and clinical endpoints.
Liu X; Xu F; Zhao K; Liu Y; Ye G; Zhang X; Qu Y
Front Immunol; 2024; 15():1344023. PubMed ID: 38312844
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
[TBL] [Abstract] [Full Text] [Related]
3. A Heart-breast cancer-on-a-Chip Platform for Disease Modeling and Monitoring of Cardiotoxicity Induced by cancer Chemotherapy.
Lee J; Mehrotra S; Zare-Eelanjegh E; Rodrigues RO; Akbarinejad A; Ge D; Amato L; Kiaee K; Fang Y; Rosenkranz A; Keung W; Mandal BB; Li RA; Zhang T; Lee H; Dokmeci MR; Zhang YS; Khademhosseini A; Shin SR
Small; 2021 Apr; 17(15):e2004258. PubMed ID: 33094918
[TBL] [Abstract] [Full Text] [Related]
4. Expression profiling identified IL-8 as a regulator of homotypic cell-in-cell formation.
Ruan B; Wang C; Chen A; Liang J; Niu Z; Zheng Y; Fan J; Gao L; Huang H; Wang X; Sun Q
BMB Rep; 2018 Aug; 51(8):412-417. PubMed ID: 30021676
[TBL] [Abstract] [Full Text] [Related]
5. BCL-X
Carné Trécesson S; Souazé F; Basseville A; Bernard AC; Pécot J; Lopez J; Bessou M; Sarosiek KA; Letai A; Barillé-Nion S; Valo I; Coqueret O; Guette C; Campone M; Gautier F; Juin PP
Nat Commun; 2017 Oct; 8(1):1123. PubMed ID: 29066722
[TBL] [Abstract] [Full Text] [Related]
6. Ectopically expressed variant form of sperm mitochondria-associated cysteine-rich protein augments tumorigenicity of the stem cell population of lung adenocarcinoma cells.
Takahashi A; Hirohashi Y; Torigoe T; Tamura Y; Tsukahara T; Kanaseki T; Kochin V; Saijo H; Kubo T; Nakatsugawa M; Asanuma H; Hasegawa T; Kondo T; Sato N
PLoS One; 2013; 8(11):e69095. PubMed ID: 24244262
[TBL] [Abstract] [Full Text] [Related]
7. Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.
Ahtiainen L; Mirantes C; Jahkola T; Escutenaire S; Diaconu I; Osterlund P; Kanerva A; Cerullo V; Hemminki A
PLoS One; 2010 Nov; 5(11):e13859. PubMed ID: 21079774
[TBL] [Abstract] [Full Text] [Related]
8. Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.
Lin WM; Karsten U; Goletz S; Cheng RC; Cao Y
Int J Exp Pathol; 2011 Apr; 92(2):97-105. PubMed ID: 21070402
[TBL] [Abstract] [Full Text] [Related]
9. Targeting the cancer initiating cell: the Achilles' heel of cancer.
McCubrey JA; Chappell WH; Abrams SL; Franklin RA; Long JM; Sattler JA; Kempf CR; Laidler P; Steelman LS
Adv Enzyme Regul; 2011; 51(1):152-62. PubMed ID: 21035484
[TBL] [Abstract] [Full Text] [Related]
10. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment.
Lagadec C; Vlashi E; Della Donna L; Meng Y; Dekmezian C; Kim K; Pajonk F
Breast Cancer Res; 2010; 12(1):R13. PubMed ID: 20158881
[TBL] [Abstract] [Full Text] [Related]
11. Chemotherapy-induced cardiotoxicity in women.
Dempsey KS
Crit Care Nurs Clin North Am; 2008 Sep; 20(3):343-50. PubMed ID: 18644518
[TBL] [Abstract] [Full Text] [Related]
12. Core imprint cytology of screen-detected breast lesions is predictive of the histologic results.
Farshid G; Pieterse S
Cancer; 2006 Jun; 108(3):150-6. PubMed ID: 16634070
[TBL] [Abstract] [Full Text] [Related]
13. [Drinking mineral waters in rehabilitation of cancer patients].
Vladimirov VI; Laktionova AI; Polushina ND
Vopr Kurortol Fizioter Lech Fiz Kult; 2004; (4):16-9. PubMed ID: 15449666
[TBL] [Abstract] [Full Text] [Related]
14. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract] [Full Text] [Related]
15. Specificity of antibody responses affected by extracorporeal immunoadsorption of plasma over columns of protein A silica.
Snyder HW; Seawell BW; Cochran SK; Balint JP; Jones FR
J Clin Apher; 1992; 7(3):110-8. PubMed ID: 1337544
[TBL] [Abstract] [Full Text] [Related]
16. [Immunologic indices of the blood and interstitial fluid in the evaluation of the treatment of secondary edemas of the upper extremities].
Kuz'mina EG; Degtiareva AA; Doroshenko LN; Rogova NM; Zorina LN
Med Radiol (Mosk); 1990 May; 35(5):18-21. PubMed ID: 2342407
[TBL] [Abstract] [Full Text] [Related]
17. Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with PROSORBA columns.
Snyder HW; Balint JP; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):31-41. PubMed ID: 2543085
[TBL] [Abstract] [Full Text] [Related]
18. [Isolation and characterization of immune complexes associated with malignant tumors and leprosy].
Segal-Eiras A; Croce MV; Ramos GS; Córsico B
Medicina (B Aires); 1989; 49(2):125-30. PubMed ID: 2640480
[TBL] [Abstract] [Full Text] [Related]
19. Protein A immunoadsorption in the treatment of malignant disease.
Messerschmidt GL; Henry DH; Snyder HW; Bertram J; Mittelman A; Ainsworth S; Fiore J; Viola MV; Louie J; Ambinder E
J Clin Oncol; 1988 Feb; 6(2):203-12. PubMed ID: 3276821
[TBL] [Abstract] [Full Text] [Related]
20. Circulating immune complexes in breast and lung cancer, before and after chemotherapy.
García MS; Barañao RI; Fernández O; Bordenave H; Rumi LS
Allergol Immunopathol (Madr); 1987; 15(1):15-8. PubMed ID: 3604838
[TBL] [Abstract] [Full Text] [Related]
[Next]
